semaglutide and crohn's Mounjaro Disease: Safety, Risks and Alternatives – Bolt Pharmacy Weight Loss Medications & IBD
Description
P.KalgutkarA
[DOI] [PMC free article] [PubMed] [Google Scholar] 36
The medication works *with* your biology rather than against your willpower
If additional glycemic control is needed after at least 4 weeks on the 1 mg dose: Increase to 2 mg subcutaneously once a week
-
For those individuals prone to obesity, their drive to eat may be more significant, their propensity to increase weight may be higher, and their ability to preserve weight is stronger
